Company intelligence / Profile preview

Neurex Corporation

Menlo Park, California, United Statesneurex.org ↗

Ownership: Private
Development stage: Commercial

Overview

Neurex developed products for pain management and acute care markets, particularly in cardiorenal and neurological diseases. Their product Corlopam was licensed to a French firm.

Therapeutic areas: CardiovascularNeurology
Modalities: Small molecules
Industry: Biotech

Drug pipeline

1 asset

ziconotide

Approved

Partnerships

Licensing agreement with a French firm (Ipsen) for Corlopam

Beyond the preview

Go deeper on Neurex Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurex Corporation.

Explore the full profile